Tag: Jon Congleton

Blood pressure medicine next to a stethoscope and a blood pressure gauge

Mineralys in Radnor Raises Funds for new Blood Pressure Treatment

Mineralys Therapeutics, a Radnor biopharmaceutical company is hoping to raise $100 million to develop a new high blood pressure treatment, writes John George for Philadelphia…

A spilled bottle of prescription pills.

Investors' Back Radnor Firm's Development of Blood Pressure Drug

Mineralys Therapeutics in Radnor is getting a $118 million investment from biotech investors in six nations to develop a new blood-pressure drug, writes Joseph…

BT Slingsby and Mineralys CEO Jon Congleton working on a treatment for hypertension

Radnor Biopharma Firm Looks at Hormone Targeting to Treat Hypertension

Mineralys Therapeutics in Radnor is on its way to developing a drug that will selectively treat hypertension, writes Laura Brzyski for Philadelphia Magazine.

Mineralys Therapeutics…